PATIENCE DAVID (Chief Financial Officer) reported 1 transaction at TRISALUS LIFE SCIENCES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/6/2026ACC: 0001628280-26-047217
Officer· Chief Financial Officer
Since Feb 2026
-14.65K
Net shares
Net seller
$65.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
14.65K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14.65K
Price / share
$4.46
Trade value
$65.34K
% of position
5.3%
7/1/2026
275.76K→261.11K
Total
Net shares
−14.65K
Net value
-$65.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | F · Tax Withholding | −14.65K | $4.46 | $65.34K | 5.3% | 275.76K | 261.11K |
| Total | −14.65K | -$65.34K | ||||||
Derivative Transactions0
No derivative transactions reported